ºÚÁÏÍø

Cardiac MRI; Advanced imaging; Myocardial tissue characterization; Stress imaging; Heart failure; Coronary artery disease, Myocardial infarction, Cardiovascular disease, MRI techniques, Cardiology

Cardiac Magnetic Resonance Imaging (CMR) has evolved into one of the most powerful imaging modalities for evaluating the cardiovascular system. With its high spatial resolution, superb tissue contrast, and ability to provide both anatomical and functional information, CMR has increasingly become a central diagnostic tool in clinical cardiology. Over the past decade, significant advancements in MRI technology have enabled the more accurate assessment of myocardial injury, ischemia, and fibrosis, offering new insights into a variety of cardiovascular diseases. This paper reviews the latest advancements in MRI techniques for cardiology, including improvements in imaging sequences, myocardial tissue characterization, and functional assessment. In addition, we examine the role of advanced MRI in assessing complex cardiovascular diseases such as ischemic heart disease, heart failure, and arrhythmias. Despite its widespread application, there are challenges associated with integrating these advanced MRI techniques into routine clinical practice, which are also discussed [1].

Cardiac MRI Core Techniques and Advancements

Cardiac MRI is primarily used to assess heart anatomy, function, and tissue characteristics. Key components of advanced cardiac MRI include

Cine MRI: This technique is used to obtain high-quality images of the heart in motion. By capturing multiple heartbeats, cine MRI allows for detailed assessment of ventricular function, including ejection fraction, wall motion, and volumes. Recent advancements in cine MRI, such as faster acquisition times and higher spatial resolution, have allowed for more accurate evaluation of left and right ventricular function [2].

Myocardial Perfusion Imaging: Perfusion imaging allows for the evaluation of blood flow to the myocardium, typically using gadolinium-based contrast agents. This technique is crucial for diagnosing coronary artery disease (CAD), as it helps identify regions of ischemia and evaluate the extent of perfusion deficits. Recent improvements in MRI perfusion imaging include the use of stress MRI, which enhances the sensitivity and specificity of ischemia detection, particularly in patients with intermediate risk of CAD.

Late Gadolinium Enhancement (LGE) Imaging: LGE imaging is used to assess myocardial fibrosis, scarring, and infarction. It is particularly valuable in the diagnosis of conditions such as myocardial infarction (MI), myocarditis, and cardiomyopathies. With enhanced spatial resolution, LGE imaging can identify subtle myocardial scars, even in cases of non-transmural infarction or early myocardial injury.

Tissue Characterization with Quantitative MRI: Advanced tissue characterization techniques such as T1 mapping, T2 mapping, and extracellular volume (ECV) mapping have been pivotal in evaluating myocardial tissue abnormalities. These techniques provide quantitative assessments of myocardial edema, fibrosis, and inflammation, improving diagnostic accuracy in conditions like myocardial infarction, heart failure, and myocarditis [3].

Myocardial Tissue Characterization in Cardiovascular Disease

One of the most significant advancements in cardiac MRI is its ability to perform non-invasive myocardial tissue characterization, providing critical information on the presence of inflammation, fibrosis, and other tissue changes associated with heart disease.

T1 and T2 Mapping: T1 and T2 mapping techniques measure the relaxation times of the myocardial tissue, which can be used to identify areas of edema, inflammation, or fibrosis. T1 mapping, for instance, is sensitive to changes in myocardial extracellular matrix composition, which is crucial for detecting early stages of fibrosis. T2 mapping is sensitive to myocardial edema, making it valuable in diagnosing conditions such as acute myocardial infarction (MI) and myocarditis [4].

Extracellular Volume (ECV) Mapping: The ECV is a novel marker for quantifying myocardial fibrosis. By measuring changes in the volume of the extracellular matrix, ECV mapping helps assess the severity of fibrosis and its distribution within the myocardium. ECV mapping has demonstrated its clinical utility in heart failure, hypertrophic cardiomyopathy (HCM), and post-infarction remodeling, providing prognostic information that can guide therapeutic strategies.

Tissue Perfusion and Viability Imaging: In ischemic heart disease, assessing myocardial perfusion and tissue viability is crucial for treatment planning. Advanced MRI techniques like myocardial perfusion imaging combined with contrast agents can identify ischemic areas and evaluate myocardial viability. The ability to differentiate between viable and non-viable myocardium is particularly useful in guiding revascularization decisions in patients with coronary artery disease (CAD).

Stress Cardiac MRI A Powerful Tool for Ischemia Detection

Stress cardiac MRI, often performed with pharmacologic agents such as adenosine or dobutamine, has become an important tool for evaluating myocardial ischemia. During a stress test, MRI images are acquired before and after inducing stress to the heart, which helps to identify areas of myocardial ischemia that may not be detectable under resting conditions. Stress MRI is highly sensitive for detecting coronary artery disease, with comparable performance to invasive coronary angiography in many cases [5].

Recent advances in stress cardiac MRI include

Faster Imaging Sequences: Newer MRI techniques such as parallel imaging and compressed sensing have significantly reduced scan times, making stress MRI more feasible in routine clinical practice. This allows for comprehensive evaluation of myocardial perfusion and wall motion during stress, improving diagnostic confidence.

Quantitative Stress MRI: Advanced post-processing techniques have enabled the quantification of stress-induced perfusion deficits, improving the accuracy of ischemia detection. These techniques are particularly useful in patients with intermediate-risk CAD who may not show obvious signs of ischemia on standard stress testing methods like treadmill exercise or stress echocardiography [6].

Role of Cardiac MRI in Heart Failure and Myocardial Infarction

Cardiac MRI plays a pivotal role in the diagnosis and management of heart failure (HF) and myocardial infarction (MI), offering detailed insights into myocardial function and tissue characterization.

Heart Failure: In heart failure, CMR allows for accurate assessment of left and right ventricular function, ventricular volumes, and myocardial scar tissue. Additionally, advanced tissue characterization techniques help identify underlying causes of heart failure, such as myocardial fibrosis, inflammation, or infiltration by abnormal cells. CMR has become the gold standard for assessing non-ischemic cardiomyopathies, including dilated cardiomyopathy and restrictive cardiomyopathy [7].

Myocardial Infarction: Following MI, CMR is essential for assessing the size and location of infarcted tissue, myocardial salvage, and ventricular remodeling. LGE imaging is particularly useful for evaluating the extent of myocardial scar tissue, while quantitative techniques like T1 and T2 mapping provide additional information on the myocardial healing process. Moreover, CMR can help predict post-infarction outcomes, including the risk of heart failure and arrhythmias.

Challenges and Limitations

Despite its significant advantages, the integration of advanced MRI techniques into routine clinical practice faces several challenges

Availability and Accessibility: High-field MRI scanners required for advanced cardiac imaging are not universally available, particularly in resource-limited settings. Furthermore, the cost and time required for performing advanced cardiac MRI techniques may limit their widespread adoption [8].

Technical Expertise: Advanced cardiac MRI techniques require specialized training and experience. Radiologists and cardiologists must be proficient in image acquisition, interpretation, and post-processing to ensure accurate and reliable results.

Patient-Related Factors: Cardiac MRI is contraindicated in some patients, such as those with implanted pacemakers or defibrillators, and may be challenging in patients with severe arrhythmias or claustrophobia. Additionally, the accuracy of CMR can be affected by factors such as heart rate, respiratory motion, and image artifacts.

Future Directions

The future of advanced MRI techniques in cardiology is promising, with several exciting developments on the horizon

3D Imaging and Artificial Intelligence (AI): The integration of 3D imaging with AI-based post-processing algorithms could significantly improve the accuracy and efficiency of cardiac MRI. AI has the potential to automate tasks such as myocardial segmentation, image analysis, and tissue characterization, making CMR more accessible and less time-consuming.

Quantitative Biomarkers: The continued development of quantitative MRI techniques for myocardial tissue characterization may lead to the discovery of new biomarkers for cardiovascular diseases. These biomarkers could improve early diagnosis, risk stratification, and monitoring of treatment response.

Molecular Imaging: Future research into molecular imaging agents could enable CMR to assess specific molecular pathways involved in cardiovascular disease. This could provide further insights into the pathophysiology of heart disease and enable more targeted therapies.

Conclusion

Advanced MRI techniques have revolutionized the way we diagnose and manage cardiovascular diseases. With their ability to provide detailed anatomical, functional, and tissue characterization, cardiac MRI plays a pivotal role in assessing heart failure, ischemic heart disease, myocardial infarction, and other cardiovascular conditions. As MRI technology continues to evolve, the integration of new techniques such as quantitative imaging, AI-based post-processing, and molecular imaging will likely enhance the diagnostic and prognostic capabilities of CMR, offering new opportunities for personalized treatment in cardiology.

1. Siva C, Brasington R, Totty W, Sotelo A, Atkinson J (2002) . J Rheumatol 29: 1088–1092.

,

2. Hanauer SB, Sandborn WJ (2019) . Am J Gastroenterol 114: 529-554.

,

3. Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, et al. (2018) . Am J Gastroenterol 113: 481-517.

, ,

4. Baumgart DC, Sandborn WJ (2012) . Lancet 380: 1590-1605.

, ,

5. Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, et al. (2018) . Lancet 390: 2769-2778.

, ,

6. Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L (2017) . Lancet 389: 1741-1755.

, ,

7. Dogramaci Y, Kalaci A, Sevinç TT, Atik E, Esen E,  et al. (2009) .J Am Podiatr Med Assoc 99: 153–156.

, ,

8. Khor B, Gardet A, Xavier RJ (2011) . Nature 474: 307-317.

, Google Scholar,